podofilox
podofilox is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Condylox. Available dosage form: gel.
Drug Details
- Generic Name
- podofilox
- Brand Names
- Condylox
- Application Number
- NDA020529
- Sponsor
- Allergan, Inc.
- NDC Codes
- 1
- Dosage Forms
- GEL
- Routes
- TOPICAL
- Active Ingredients
- PODOFILOX
Indications and Usage
INDICATIONS AND USAGE Condylox Gel 0.5% is indicated for the topical treatment of anogenital warts (external genital warts and perianal warts). This product is not indicated in the treatment of mucous membrane warts (see PRECAUTIONS ). Diagnosis Although anogenital warts have a characteristic appearance, histopathologic confirmation should be obtained if there is any doubt of the diagnosis. Differentiating warts from squamous cell carcinoma and "Bowenoid papulosis" is of particular concern. Squamous cell carcinoma may also be associated with human papillomavirus which should not be treated with Condylox Gel 0.5%.
Warnings
WARNINGS Correct diagnosis of the lesions to be treated is essential. See the Diagnosis subsection of the INDICATIONS AND USAGE section. Condylox Gel 0.5% is intended for cutaneous use only. Avoid contact with the eyes. If contact with the eyes occurs, patients should immediately flush the eyes with copious quantities of water and seek medical advice. Drug Product is Flammable. Keep Away f rom Open Flame.